BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Pfizer Inc. (PFE)'s Cancer Drug Sutent Linked to Severe Skin Reactions


9/9/2013 8:05:47 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The manufacturer of a drug used to treat several types of cancer is warning that the medication has been linked with rare but potentially fatal skin rashes. Sutent, made by Pfizer Canada Inc., is used to treat cancers of the stomach and bowels, kidney, and pancreas. In a Health Canada advisory Friday, the company said Sutent (sunitinib malate) has been associated in some people with severe skin rashes, among them Stevens-Johnson syndrome and toxic epidermal necrolysis.

Help employers find you! Check out all the jobs and post your resume.


Read at CTV.ca
Read at CBC
Read at News Release

CTV.ca
CBC
News Release
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES